Integrating chemotherapy, radiotherapy, and O6-methylguanine-DNA methyltransferase (MGMT) status with deep-learning cellular tumor volumetry sharpens prediction of glioblastoma recurrence on postoperative MRI
- DOI
- 10.1093/noajnl/vdag178
- Published
- 2026-01
- Container
- Neuro-Oncology Advances
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/noajnl/vdag178,
title = {Integrating chemotherapy, radiotherapy, and O6-methylguanine-DNA methyltransferase (MGMT) status with deep-learning cellular tumor volumetry sharpens prediction of glioblastoma recurrence on postoperative MRI},
author = {Taha Belbadaoui and Andrew Forester and Farzad Khalvati and Louis Gagnon},
year = {2026},
journal = {Neuro-Oncology Advances},
doi = {10.1093/noajnl/vdag178},
url = {https://doi.org/10.1093/noajnl/vdag178}
}RIS
TY - JOUR TI - Integrating chemotherapy, radiotherapy, and O6-methylguanine-DNA methyltransferase (MGMT) status with deep-learning cellular tumor volumetry sharpens prediction of glioblastoma recurrence on postoperative MRI AU - Taha Belbadaoui AU - Andrew Forester AU - Farzad Khalvati AU - Louis Gagnon PY - 2026 JO - Neuro-Oncology Advances DO - 10.1093/noajnl/vdag178 UR - https://doi.org/10.1093/noajnl/vdag178 ER -
APA
Belbadaoui, T., Forester, A., Khalvati, F., & Gagnon, L. (2026). Integrating chemotherapy, radiotherapy, and O6-methylguanine-DNA methyltransferase (MGMT) status with deep-learning cellular tumor volumetry sharpens prediction of glioblastoma recurrence on postoperative MRI. Neuro-Oncology Advances. https://doi.org/10.1093/noajnl/vdag178
Source records
- crossref · retrieved 2026-09-27T12:07:41.943Z